Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-24-000141

Chief Accounting Officer sold 1,357 shares at $14.97 ($20,314)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Azoy Alexander Chief Accounting Officer 2024-08-13 Sale 10b5-1 −1,357 $14.97 $20,314 19,070 D: show line 1 in the form
Open-market sales · 1,357 sh · avg $14.97 · $20,314
Loading xslF345X05/wk-form4_1723754700.xml…